Less than two months since a pair of mid-stage setbacks crushed its stock price, researchers at Zynerba $ZYNE say they had better results from a … Read More
The post After getting crushed by bad data, Zynerba says its cannabis -based drug worked on Fragile X … appeared first on Dagga Magazine.